We recently published a list of 8 High Growth High Margin Stocks to Invest In Now. In this article, we are going to take a ...

Imagine you wake up in a hospital without a single memory of the last month. Doctors say you had a series of violent episodes ...

In one of the case reports, a 75-year-old White man with hereditary coagulopathy presented with myasthenic crisis in the setting of acute pulmonary embolism. Chronic symptoms included diplopia, ptosis ...

Scientists have discovered a new process in our immune systems that leads to the production of an important family of anti-viral proteins called interferons. They hope the discovery will now lead to ...

STAT reporters discuss investors' interest in autoimmune disease, GLP-1 supply issues, and big moments from #STATSummit.

Taiwan’s REGiMMUNE and Europe-based Kiji Therapeutics are merging to create a globally minded regulatory T-cell biotech that ...

Plasma exchange therapy, typically used to treat rare autoimmune disorders, is becoming a trendy longevity procedure. Here's ...

Clinical stage biopharma Kezar Life Sciences is discontinuing its lupus nephritis (LN) clinical programme following the death ...

In a perspective article published in Science, Professor Jonathan Rivnay explores next-generation bioelectronic medication.

New data released by Merck suggests AstraZeneca and Sanofi’s Beyfortus, the monoclonal antibody injection that protects ...